Updates to Advanced Prostate Cancer: AUA/SUO Guideline (2023)
- PMID: 37096583
- DOI: 10.1097/JU.0000000000003452
Updates to Advanced Prostate Cancer: AUA/SUO Guideline (2023)
Abstract
Purpose: In 2022 the American Urological Association (AUA) requested an Update Literature Review (ULR) to incorporate new evidence generated since the 2020 publication of this guideline. The resulting 2023 Guideline Amendment addresses updated recommendations for patients with advanced prostate cancer.
Materials and methods: The ULR addressed 23 of the original 38 guideline statements and included an abstract-level review of eligible studies published since the 2020 systematic review. Sixteen studies were selected for full text review. The current summary presents the updates made to the Guideline as a result of that new literature.
Results: The Advanced Prostate Cancer Panel amended evidence- and consensus-based statements based on an updated review to aid clinicians in the management of patients with advanced prostate cancer. These statements are detailed herein.
Conclusion: This Guideline Amendment provides a framework designed to improve a clinician's ability to treat patients diagnosed with advanced prostate cancer with the most current evidence-based information. Further research and publication of high-quality clinical trials will be essential to continue to improve the quality of care for these patients.
Keywords: ADT; MDT; advanced; cancer; mCRPC; mHSPC; men; metastasis; prostate cancer.
Similar articles
-
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I.J Urol. 2021 Jan;205(1):14-21. doi: 10.1097/JU.0000000000001375. Epub 2020 Sep 22. J Urol. 2021. PMID: 32960679
-
Updates to Incontinence After Prostate Treatment: AUA/GURS/SUFU Guideline (2024).J Urol. 2024 Oct;212(4):531-538. doi: 10.1097/JU.0000000000004088. Epub 2024 Jun 27. J Urol. 2024. PMID: 38934789
-
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II.J Urol. 2021 Jan;205(1):22-29. doi: 10.1097/JU.0000000000001376. Epub 2020 Sep 22. J Urol. 2021. PMID: 32960678
-
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline: 2024 Amendment.J Urol. 2024 Apr;211(4):533-538. doi: 10.1097/JU.0000000000003846. Epub 2024 Jan 24. J Urol. 2024. PMID: 38265030 Review.
-
EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study).Eur Urol. 2019 Dec;76(6):790-813. doi: 10.1016/j.eururo.2019.09.020. Epub 2019 Oct 3. Eur Urol. 2019. PMID: 31587989 Review.
Cited by
-
Treatment intensification with radium-223 plus enzalutamide in patients with metastatic castration-resistant prostate cancer.Front Med (Lausanne). 2024 Oct 24;11:1460212. doi: 10.3389/fmed.2024.1460212. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39526247 Free PMC article. Review.
-
BRCA Mutation Testing in Men With Metastatic Castration-Resistant Prostate Cancer: Practical Guidance for Australian Clinical Practice.Asia Pac J Clin Oncol. 2025 Aug;21(4):345-358. doi: 10.1111/ajco.14150. Epub 2025 Jan 18. Asia Pac J Clin Oncol. 2025. PMID: 39825869 Free PMC article. Review.
-
Real-World Evidence of Combination Therapy Use in Metastatic Hormone-Sensitive Prostate Cancer in the United States From 2017 to 2023.JCO Oncol Pract. 2025 Aug;21(8):1174-1184. doi: 10.1200/OP-24-00690. Epub 2025 Feb 7. JCO Oncol Pract. 2025. PMID: 39919261 Free PMC article.
-
Evaluating first-line therapeutic strategies for metastatic castration-resistant prostate cancer: a comprehensive network meta-analysis and systematic review.Front Oncol. 2024 Apr 15;14:1378993. doi: 10.3389/fonc.2024.1378993. eCollection 2024. Front Oncol. 2024. PMID: 38686197 Free PMC article.
-
A modified Delphi consensus regarding the clinical utility of triplet therapy in patients with metastatic hormone-sensitive prostate cancer patients in the UK.BMJ Open. 2024 Nov 27;14(11):e090013. doi: 10.1136/bmjopen-2024-090013. BMJ Open. 2024. PMID: 39609017 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical